UPDATE: Galena Biopharma (GALE) Stock Hit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Equities rebound to close higher as surging Treasury yields recede
- Fed’s Jefferson sees no urgency for another rate increase
- Oil jumps 4% on reports China halts fuel exports, US troops head to Middle East
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Anthropic targets mid-November for public debut - report
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- Trump Media and TAE Technologies file S-4 for all-stock merger
Galena Biopharma (GALE) Gains Following Positive Comments from Doctor
February 20, 2014 10:38 AM ESTGalena Biopharma (Nasdaq: GALE) gained following positive comments from a medical oncologist and hematologist posted on Seeking Alpha. Link Here... More
Galena Biopharma (GALE) Responds to TheStreet.com
February 14, 2014 3:26 PM ESTGalena Biopharma (Nasdaq: GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today issued a letter to its shareholders in response to recent media attention stemming from an article by TheStreet.com.
Dear Shareholders:
Due to the recent media attention on Galena Biopharma that we acknowledge is having an impact on investor confidence, we felt it necessary, as a service to our shareholders, to publicly respond to the discussions and set the record straight.
The... More
UPDATE: Galena Biopharma (GALE) Declines Following Negative Comments from Adam Feuerstein
February 12, 2014 10:02 AM EST(Updated - February 12, 2014 10:11 AM EST)
Galena Biopharma (Nasdaq: GALE) stock declined on Wednesday after negative comments from TheStreet.com's Adam Feuerstein. Link Here... More
